TLCM
WST icon

Tiger Legatus Capital Management’s West Pharmaceutical WST Stock Holding History

Tiger Legatus Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-100,000
Closed -$4.48M – 18
2014
Q3 		$4.48M Sell
100,000
-80,000
-44% -$3.4M 1.59% 14
2014
Q2 		$7.59M Buy
180,000
+40,000
+29% +$1.71M 2.87% 11
2014
Q1 		$6.17M Buy
140,000
+15,000
+12% +$706K 2.47% 13
2013
Q4 		$6.13M Buy
+125,000
New +$5.85M 3.39% 11

Other funds holding WST

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Tiger Legatus Capital Management's WST Position: Q4 2014 in Review

Tiger Legatus Capital Management sold out of West Pharmaceutical (WST) in Q4 2014, closing a stake of 100,000 shares — an estimated $4.48M sold.

Tiger Legatus Capital Management first reported a position in WST in Q4 2013 and held it in 4 quarters. The position peaked at $7.59M in Q2 2014. 225 funds tracked by Wall St. Rank hold WST as of Q4 2014.

  • Tiger Legatus Capital Management reported no remaining West Pharmaceutical position as of Q4 2014 after selling out during the quarter.
  • Tiger Legatus Capital Management sold 100,000 West Pharmaceutical shares in Q4 2014, an estimated $4.48M.
  • Tiger Legatus Capital Management first reported a position in West Pharmaceutical in Q4 2013 and held it in 4 quarters.
  • Tiger Legatus Capital Management's West Pharmaceutical position peaked at $7.59M in Q2 2014.
  • 225 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2014.

Based on Tiger Legatus Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.